Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 616 AL 630

Assessment and Validation of Globodera pallida as a Novel In Vivo Model for Studying Alzheimer's Disease

Althobaiti NA, Menaa F, Albalawi AE, Dalzell JJ, Warnock ND, Mccammick EM, Alsolais A, Alkhaibari AM, Green BD.

Cells. 2021 Sep 19;10(9):2481. doi: 10.3390/cells10092481.

Looking at Alzheimer's Disease Pathogenesis from the Nuclear Side

D'Andrea L, Stringhi R, Di Luca M, Marcello E.

Biomolecules. 2021 Aug 24;11(9):1261. doi: 10.3390/biom11091261.

Insulin and Insulin Resistance in Alzheimer's Disease

Sędzikowska A, Szablewski L.

Int J Mol Sci. 2021 Sep 15;22(18):9987. doi: 10.3390/ijms22189987.

The Hidden Side of NCAM Family: NCAM2, a Key Cytoskeleton Organization Molecule Regulating Multiple Neural Functions

Parcerisas A, Ortega-Gascó A, Pujadas L, Soriano E.

Int J Mol Sci. 2021 Sep 16;22(18):10021. doi: 10.3390/ijms221810021.

Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer's Disease

Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S.

Int J Mol Sci. 2021 Sep 20;22(18):10139. doi: 10.3390/ijms221810139.

Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease

Chan HJ, Yanshree, Roy J, Tipoe GL, Fung ML, Lim LW.

Int J Mol Sci. 2021 Sep 21;22(18):10151. doi: 10.3390/ijms221810151.

Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer's Disease

Uliassi E, de Oliveira AS, de Camargo Nascente L, Romeiro LAS, Bolognesi ML.

Molecules. 2021 Sep 7;26(18):5441. doi: 10.3390/molecules26185441.

Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources

Tamfu AN, Kucukaydin S, Yeskaliyeva B, Ozturk M, Dinica RM.

Molecules. 2021 Sep 14;26(18):5582. doi: 10.3390/molecules26185582.

Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease

Jain D, Rashid MA, Ahmad FJ.

Curr Pharm Des. 2021;27(43):4388-4403. doi: 10.2174/1381612827666210927163258.

Personalized prediction of progression in pre-dementia patients based on individual biomarker profile: A development and validation study

Kühnel L, Bouteloup V, Lespinasse J, Chêne G, Dufouil C, Molinuevo JL, Raket LL; MEMENTO study group and the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2021 Dec;17(12):1938-1949. doi: 10.1002/alz.12363. Epub 2021 Sep 28.

The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)

Costa N, Mounié M, Pagès A, Derumeaux H, Rapp T, Guyonnet S, Coley N, Cantet C, Carrié I, Andrieu S, Molinier L.

J Prev Alzheimers Dis. 2021;8(4):425-435. doi: 10.14283/jpad.2021.47.

SERPINA3 in glioblastoma and Alzheimer's disease

Norton ES, Da Mesquita S, Guerrero-Cazares H.

Aging (Albany NY). 2021 Sep 29;13(18):21812-21813. doi: 10.18632/aging.203603. Epub 2021 Sep 29.

Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route

Tripathi S, Gupta U, Ujjwal RR, Yadav AK.

J Microencapsul. 2021 Nov-Dec;38(7-8):572-593. doi: 10.1080/02652048.2021.1986585. Epub 2021 Nov 9.

Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations

Mani S, Swargiary G, Singh M, Agarwal S, Dey A, Ojha S, Jha NK.

Life Sci. 2021 Nov 15;285:119985. doi: 10.1016/j.lfs.2021.119985. Epub 2021 Sep 27.

Brain Exosomes: Friend or Foe in Alzheimer's Disease?

Kaur S, Verma H, Dhiman M, Tell G, Gigli GL, Janes F, Mantha AK.

Mol Neurobiol. 2021 Dec;58(12):6610-6624. doi: 10.1007/s12035-021-02547-y. Epub 2021 Sep 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias